First Quadrant’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-146
| Closed | -$20K | – | 137 |
|
|
2021
Q4 | $20K | Buy |
146
+26
| +22% | +$3.07K | ﹤0.01% | 469 |
|
|
2021
Q3 | $13K | Buy |
+120
| New | +$13.7K | ﹤0.01% | 504 |
|
|
2021
Q2 | – | Sell |
-3,522
| Closed | -$381K | – | 511 |
|
|
2021
Q1 | $381K | Buy |
3,522
+60
| +2% | +$6.42K | 0.04% | 299 |
|
|
2020
Q4 | $371K | Sell |
3,462
-3,910
| -53% | -$376K | 0.04% | 287 |
|
|
2020
Q3 | $646K | Sell |
7,372
-7,850
| -52% | -$739K | 0.08% | 192 |
|
|
2020
Q2 | $1.49M | Sell |
15,222
-2,912
| -16% | -$256K | 0.2% | 121 |
|
|
2020
Q1 | $1.38M | Buy |
18,134
+1,165
| +7% | +$99.2K | 0.2% | 127 |
|
|
2019
Q4 | $1.5M | Buy |
16,969
+600
| +4% | +$49.8K | 0.13% | 159 |
|
|
2019
Q3 | $1.24M | Sell |
16,369
-31,730
| -66% | -$2.18M | 0.12% | 186 |
|
|
2019
Q2 | $3.5M | Sell |
48,099
-212
| -0.4% | -$16.7K | 0.24% | 100 |
|
|
2019
Q1 | $3.89M | Buy |
48,311
+1,359
| +3% | +$111K | 0.3% | 74 |
|
|
2018
Q4 | $4.33M | Sell |
46,952
-569
| -1% | -$50K | 0.35% | 61 |
|
|
2018
Q3 | $4.5M | Sell |
47,521
-356,175
| -88% | -$33.8M | 0.1% | 219 |
|
|
2018
Q2 | $37.4M | Buy |
403,696
+33
| +0% | +$3.22K | 0.7% | 19 |
|
|
2018
Q1 | $38.2M | Buy |
403,663
+43,050
| +12% | +$4.73M | 0.73% | 15 |
|
|
2017
Q4 | $34.9M | Buy |
360,613
+176,870
| +96% | +$16.7M | 0.65% | 20 |
|
|
2017
Q3 | $16.3M | Buy |
183,743
+138,042
| +302% | +$10.5M | 0.32% | 117 |
|
|
2017
Q2 | $3.31M | Buy |
45,701
+7,101
| +18% | +$477K | 0.07% | 276 |
|
|
2017
Q1 | $2.52M | Buy |
38,600
+2,100
| +6% | +$132K | 0.05% | 321 |
|
|
2016
Q4 | $2.29M | Sell |
36,500
-54,006
| -60% | -$3.3M | 0.05% | 327 |
|
|
2016
Q3 | $5.71M | Buy |
90,506
+306
| +0.3% | +$19.8K | 0.12% | 221 |
|
|
2016
Q2 | $5.58M | Buy |
90,200
+9,900
| +12% | +$603K | 0.12% | 196 |
|
|
2016
Q1 | $4.59M | Sell |
80,300
-2,000
| -2% | -$111K | 0.1% | 215 |
|
|
2015
Q4 | $4.88M | Sell |
82,300
-34,800
| -30% | -$2M | 0.11% | 211 |
|
|
2015
Q3 | $6.37M | Sell |
117,100
-87,300
| -43% | -$5.68M | 0.14% | 181 |
|
|
2015
Q2 | $13.7M | Buy |
204,400
+175,800
| +615% | +$11.5M | 0.29% | 109 |
|
|
2015
Q1 | $1.67M | Sell |
28,600
-113,882
| -80% | -$6.88M | 0.03% | 297 |
|
|
2014
Q4 | $9.32M | Sell |
142,482
-99
| -0.1% | -$6.24K | 0.2% | 144 |
|
|
2014
Q3 | $8.23M | Sell |
142,581
-5,900
| -4% | -$328K | 0.18% | 148 |
|
|
2014
Q2 | $8.38M | Buy |
148,481
+63,600
| +75% | +$3.34M | 0.19% | 156 |
|
|
2014
Q1 | $4.36M | Sell |
84,881
-4,501
| -5% | -$227K | 0.1% | 210 |
|
|
2013
Q4 | $4.72M | Buy |
89,382
+853
| +1% | +$41.9K | 0.11% | 203 |
|
|
2013
Q3 | $3.96M | Sell |
88,529
-34,171
| -28% | -$1.51M | 0.1% | 220 |
|
|
2013
Q2 | $5.07M | Buy |
+122,700
| New | +$5.37M | 0.14% | 191 |
|
Other funds holding ABBV
First Quadrant's ABBV Position: Q1 2022 in Review
First Quadrant sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 146 shares — an estimated $20K sold.
First Quadrant first reported a position in ABBV in Q2 2013 and held it in 34 quarters. The position peaked at $38.2M in Q1 2018. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.
- First Quadrant reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
- First Quadrant sold 146 AbbVie shares in Q1 2022, an estimated $20K.
- First Quadrant first reported a position in AbbVie in Q2 2013 and held it in 34 quarters.
- First Quadrant's AbbVie position peaked at $38.2M in Q1 2018.
- 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.
Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.